• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

March 30-31, 2011: Food Advisory Committee Meeting Announcement

Center Date Time Location
CFSAN March 30 - 31, 2011 8:30 a.m. – 4:30 p.m. Hilton Hotel
8727 Colesville Road
Silver Spring, MD 20910

Agenda

The Food Advisory Committee will meet to discuss whether available relevant data demonstrate a link between children's consumption of synthetic color additives in food and adverse effects on behavior.

Meeting Materials

FDA intends to make the complete set of background materials available to the public no later than 2 days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, all efforts will be made to try and provide the background material at the location of the advisory committee meeting, and the background material will be posted on FDA's Web site after the meeting.

Public Participation and Sponsor Information

  • Written submissions may be made to the contact person on or before March 23, 2011. Comments received on or before March 23, 2011 will be provided to the committee before the meeting.
  • Oral presentations from the public (excluding Sponsors) will be scheduled between approximately 10:45 a.m. and 11:45 am on March 31, 2011. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before March 15, 2011.

Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by March 22, 2011.

Contact Information

Carolyn Jeletic
Office of Regulations, Policy and Social Sciences, HFS-024
Center for Food Safety and Applied Nutrition
5100 Paint Branch Parkway
College Park, Maryland 20740

Phone: 301-436-1913
Fax: 301-436-2637
E-mail: Carolyn.Jeletic@fda.hhs.gov

  • FDA Advisory Committee Information Line
    1-800-741-8138
    (301-443-0572 in the Washington DC area)
    Code: 3014510564
    Please call the Information Line for up-to-date information on this meeting.

A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the agency's Web site and call the appropriate advisory committee hot line/phone line to learn about possible modifications before coming to the meeting.

FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA's Web site after the meeting.

Persons attending FDA's advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Carolyn Jeletic at 301-436-1913 at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site for procedures on public conduct during advisory committee meetings.

Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2).